News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boston Scientific Corporation (BSX) Issues Update On Medinol Ltd. Litigation


10/19/2005 5:09:08 PM

NATICK, Mass., Aug. 12 /PRNewswire-FirstCall/ -- Commenting on the status of the current litigation between Boston Scientific Corporation and Medinol, Ltd. in federal district court in New York, Boston Scientific spokesman Paul Donovan today said: "Although the parties have been engaged in settlement discussions, no agreement has been reached. The trial is scheduled to resume on September 19."

Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

This press release contains forward-looking statements. The Company wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with litigation and other factors described in the Company's filings with the Securities and Exchange Commission.

CONTACT: Milan Kofol 508-650-8569 Investor Relations Boston Scientific Corporation Paul Donovan 508-667-5165 (Mobile) Media Relations Boston Scientific Corporation Boston Scientific Corporation

CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569, or PaulDonovan, Media Relations, Mobile, +1-508-667-5165, both of BostonScientific Corporation


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES